MAPS Study on Cannabis for PTSD Finally Concludes

Share this with your friends

The research conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS) has been a major driving factor for changing drug policies in the United States. MAPS is an incredible organization that has been working to break down the barriers of prohibition since well before the cause was “cool.”

The completion of their most recent controlled trial could have very beneficial consequences for individuals with post-traumatic stress disorder (PTSD), especially veterans. MAPS funded a study looking at how whole plant cannabis impacted 76 veterans with diagnosed PTSD.

The research, conducted by Dr. Suzanne Sisley , MD, encountered numerous obstacles along the way. Research schools backed out of the study. That and other issues with enrolling veterans caused substantial delay.

In the end, it took nearly a decade to complete this clinical trial. However, the research itself had the support of multiple organizations, including veterans advocacy groups and cannabis legalization organizations.

Ideally, the outcome of this research will help convince the Veterans Administration (VA) to allow veterans to use cannabis for their PTSD. The final outcome and results of the study have yet to be released. However, anecdotal evidence up to this point makes it very likely that the outcome will support allowing access to cannabis medicine for those who struggle with PTSD. If the study itself does little to sway others, hopefully it will pave the way for similar studies in the near future.

For previous Ladybud articles about MAPS, click here.